950 related articles for article (PubMed ID: 28660349)
1. Tumor-Associated Macrophages as Target for Antitumor Therapy.
Sawa-Wejksza K; Kandefer-Szerszeń M
Arch Immunol Ther Exp (Warsz); 2018 Apr; 66(2):97-111. PubMed ID: 28660349
[TBL] [Abstract][Full Text] [Related]
2. Tumor-associated macrophages: implications in cancer immunotherapy.
Petty AJ; Yang Y
Immunotherapy; 2017 Mar; 9(3):289-302. PubMed ID: 28231720
[TBL] [Abstract][Full Text] [Related]
3. Preclinical and Clinical Therapeutic Strategies Affecting Tumor-Associated Macrophages in Hepatocellular Carcinoma.
Degroote H; Van Dierendonck A; Geerts A; Van Vlierberghe H; Devisscher L
J Immunol Res; 2018; 2018():7819520. PubMed ID: 30410942
[TBL] [Abstract][Full Text] [Related]
4. New Mechanisms of Tumor-Associated Macrophages on Promoting Tumor Progression: Recent Research Advances and Potential Targets for Tumor Immunotherapy.
Guo Q; Jin Z; Yuan Y; Liu R; Xu T; Wei H; Xu X; He S; Chen S; Shi Z; Hou W; Hua B
J Immunol Res; 2016; 2016():9720912. PubMed ID: 27975071
[TBL] [Abstract][Full Text] [Related]
5. Blockade of DC-SIGN
Hu B; Wang Z; Zeng H; Qi Y; Chen Y; Wang T; Wang J; Chang Y; Bai Q; Xia Y; Wang Y; Liu L; Zhu Y; Dai B; Guo J; Xu L; Zhang W; Xu J
Cancer Res; 2020 Apr; 80(8):1707-1719. PubMed ID: 32060149
[TBL] [Abstract][Full Text] [Related]
6. Targeting tumor associated macrophages (TAMs) via nanocarriers.
Singh Y; Pawar VK; Meher JG; Raval K; Kumar A; Shrivastava R; Bhadauria S; Chourasia MK
J Control Release; 2017 May; 254():92-106. PubMed ID: 28377038
[TBL] [Abstract][Full Text] [Related]
7. Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.
Jia XH; Feng GW; Wang ZL; Du Y; Shen C; Hui H; Peng D; Li ZJ; Kong DL; Tian J
Oncotarget; 2016 Apr; 7(15):20934-44. PubMed ID: 26988913
[TBL] [Abstract][Full Text] [Related]
8. Cancer-promoting tumor-associated macrophages: new vistas and open questions.
Mantovani A; Germano G; Marchesi F; Locatelli M; Biswas SK
Eur J Immunol; 2011 Sep; 41(9):2522-5. PubMed ID: 21952810
[TBL] [Abstract][Full Text] [Related]
9. Progress in tumor-associated macrophage (TAM)-targeted therapeutics.
Ngambenjawong C; Gustafson HH; Pun SH
Adv Drug Deliv Rev; 2017 May; 114():206-221. PubMed ID: 28449873
[TBL] [Abstract][Full Text] [Related]
10. Tumor promoting role of anti-tumor macrophages in tumor microenvironment.
Goswami KK; Ghosh T; Ghosh S; Sarkar M; Bose A; Baral R
Cell Immunol; 2017 Jun; 316():1-10. PubMed ID: 28433198
[TBL] [Abstract][Full Text] [Related]
11. The Impact of the Tumor Microenvironment on Macrophage Polarization in Cancer Metastatic Progression.
Wang H; Yung MMH; Ngan HYS; Chan KKL; Chan DW
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34207286
[TBL] [Abstract][Full Text] [Related]
12. Targeting tumor-associated macrophages: A potential treatment for solid tumors.
Chen Y; Jin H; Song Y; Huang T; Cao J; Tang Q; Zou Z
J Cell Physiol; 2021 May; 236(5):3445-3465. PubMed ID: 33200401
[TBL] [Abstract][Full Text] [Related]
13. Targeting tumor-associated macrophages for cancer immunotherapy.
Shu Y; Cheng P
Biochim Biophys Acta Rev Cancer; 2020 Dec; 1874(2):188434. PubMed ID: 32956767
[TBL] [Abstract][Full Text] [Related]
14. Engineering Macrophages for Cancer Immunotherapy and Drug Delivery.
Xia Y; Rao L; Yao H; Wang Z; Ning P; Chen X
Adv Mater; 2020 Oct; 32(40):e2002054. PubMed ID: 32856350
[TBL] [Abstract][Full Text] [Related]
15. Harnessing tumor-associated macrophages as aids for cancer immunotherapy.
Li X; Liu R; Su X; Pan Y; Han X; Shao C; Shi Y
Mol Cancer; 2019 Dec; 18(1):177. PubMed ID: 31805946
[TBL] [Abstract][Full Text] [Related]
16. Tumor-associated macrophages in cancer: recent advancements in cancer nanoimmunotherapies.
Kumari N; Choi SH
J Exp Clin Cancer Res; 2022 Feb; 41(1):68. PubMed ID: 35183252
[TBL] [Abstract][Full Text] [Related]
17. Current Strategies to Target Tumor-Associated-Macrophages to Improve Anti-Tumor Immune Responses.
Anfray C; Ummarino A; Andón FT; Allavena P
Cells; 2019 Dec; 9(1):. PubMed ID: 31878087
[No Abstract] [Full Text] [Related]
18. Tumor-associated myeloid cells as guiding forces of cancer cell stemness.
Sica A; Porta C; Amadori A; Pastò A
Cancer Immunol Immunother; 2017 Aug; 66(8):1025-1036. PubMed ID: 28401258
[TBL] [Abstract][Full Text] [Related]
19. The role of tumor-associated macrophages in tumor immune evasion.
Huang R; Kang T; Chen S
J Cancer Res Clin Oncol; 2024 May; 150(5):238. PubMed ID: 38713256
[TBL] [Abstract][Full Text] [Related]
20. Molecular Repolarisation of Tumour-Associated Macrophages.
van Dalen FJ; van Stevendaal MHME; Fennemann FL; Verdoes M; Ilina O
Molecules; 2018 Dec; 24(1):. PubMed ID: 30577495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
